Sponsor pipeline

iCell Gene Therapeutics clinical trial pipeline

Get alerts when iCell Gene Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
4
Phase 1/2
1
Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07328581 A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or… Systemic Lupus Erythematosus (SLE) Recruiting 2026-09-17
Phase 1/2
NCT07544160 BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) Inflammatory Bowel Diseases (IBD) Not Yet Recruiting 2026-04-22
Phase 1
NCT07715136 BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy Inflammatory Myopathy Recruiting 2026-07-20
NCT07668557 Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute… Acute Myeloid Leukemia (AML) Recruiting 2026-06-25
NCT04162353 BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma Multiple Myeloma in Relapse Recruiting 2025-09-16
NCT06787989 BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with… Refractory Immune Cytopenia Recruiting 2025-01-22

Disease areas by active trials

Acute Myeloid Leukemia (AML) (1) · Crohn's Disease (1) · Leukemia (1) · Lupus (SLE) (1) · Multiple Myeloma (1) · Ulcerative Colitis (1)

Get alerts when iCell Gene Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free